Fragment analogs as better mimics of obestatin

Regulatory Peptides

Volumn 158, Issue 1-3, 2009, Pages 143-148

  Nagaraj, ShreeRanga ^a   Peddha, Muthukumar S ^a   Manjappara, Uma V ^a  

^a CENTRAL FOOD TECHNOLOGICAL RESEARCH INSTITUTE   (India)

Author keywords

Aminoisobutyric acid (Aib, U); Cyclohexylalanine (Cha); Middle fragment; N terminal peptide; Obestatin

Indexed keywords

2 AMINO 2 METHYLPROPIONIC ACID; AMINO ACID; CHOLESTEROL; GLYCINE; OBESTATIN; PEPTIDE; TRIACYLGLYCEROL; URIDINE;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EPIDIDYMIS FAT; FOOD INTAKE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MODIFICATION; PROTEIN SECONDARY STRUCTURE; PROTEIN SYNTHESIS INHIBITION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ANIMALS; BODY WEIGHT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRINKING BEHAVIOR; FEEDING BEHAVIOR; GHRELIN; LIPID METABOLISM; MICE; MOLECULAR MIMICRY; PANCREATIN; PEPTIDE FRAGMENTS;

MUS; RODENTIA;

EID: 70349742794     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2009.08.008     Document Type: Article

References (28)

1. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., and Hsuch A.J. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effect on food intake. Science 310 (2005) 996-999
2. Groucerol G., Million M., Adelson D.W., Wang Y., Wang L., Rivier J., St-Pierre D.H., and Tache Y. Lack of interaction between peripheral injection of CCK and obestatin in the regulation of gastric satiety signaling in rodents. Peptides 27 (2006) 2811-2819
3. Nogueiras R., Pfluger P., Tovar S., Arnold M., Mitchell S., Morris A., Perez-Tilve D., Vazquez M.J., Wiedmer P., Castaneda R.T., DiMarchi R., Tschop M., Schurmann A., Joost H., Williams L.M., Langhans W., and Dieguez C. Effect of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 148 (2007) 21-26
4. Yamamoto D., Ikeshita N., Daito R., Herningtyas E.H., Toda K., Takahashi K., Iida K., Takahashi Y., Kaji h., Chihara k., and Okimura Y. Neither intravenous nor intracerebroventricular administration of obestatin affects the secretion of GH, PRL, TSH and ATCH in rats. Regul Pept 138 (2007) 141-144
5. Bassil A.K., Haglund Y., Brown J., Rudholm T., Hellstrom P.M., Naslund E., Lee K., and Sanger G.J. Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tract. Br J Pharmacol 150 (2007) 58-64
6. De Smet B., Thijs T., Peeters T.L., and Depoortere I. Effect of peripheral obestatin on gastric emptying and intestinal contractility in rodents. Neurogastroenterol Motil 19 (2007) 211-217
7. Bresciani R., Rapetti D., Donà F., Bulgarelli I., Tamiazzo L., Locatelli V., and Torsello A. Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat. Endocrinol Invest 29 (2006) RC16-8
8. Fujimiya M., Ataka K., Asakawa A., and Inui A. Obestatin inhibits gastroduodenal motility in conscious fed rats via POMC pathway and CRF receptors in the brain. Auton Neurosci 135 (2007) 41
9. Gao X.Y., Luang H.Y., Liu X.M., Wang X.Y., and Pan Y.H. Decreased obestatin in plasma in metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Res Clin Pract 9 (2008) e5-6
10. Green B.D., Irwin N., and Flatt P.R. Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice. Peptides 28 (2007) 981-987
11. Guo Z.F., Zheng X., Qin Y.W., Hu J.Q., Chen S.P., and Zhang Z. Circulating preprandial ghrelin to obestatin ratio is increased in human obesity. J Clin Endocrin Metab 29 (2007) 875-880
12. Lagaud G.J., Young A., Acena A., Morton M.F., Barrett T.D., and Shankley N.P. Obestatin reduces food intake and suppresses body weight gain in rodents. Biochem Biophys Res Commun 357 (2007) 264-269
13. Nagaraj S., Peddha M.S., and Manjappara U.V. Fragments of obestatin as modulators of feed intake, circulating lipids, and stored fat. Biochem Biophys Res Commun 366 (2008) 731-737
14. Prasad B.V., and Balaram P. The stereochemistry of peptides containing alpha-aminoisobutyric acid. CRC Crit Rev Biochem 16 (1984) 307-348
15. Banerjee R., Basu G., Chene P., and Roy S. Aib-based peptide backbone as scaffolds for helical peptide mimics. J Pept Res 60 (2002) 88-94
16. Schweitzer-Stenner R., Gonzales W., Bourne G.T., Feng J.A., and Bourne G.R. Conformational manifold of α-aminoisobutyricacid (Aib) containing alanine-based tripeptides in aqueous solution explored by vibrational spectroscopy and molecular dynamics stimulations. J Am Chem Soc 129 (2007) 13095-13109
17. Vergote V., Van Dorpe S., Peremans K., Burvenich C., and Spiegeleer B.D. In vitro metabolic stability of obestatin: kinetics and identification of cleavage products. Peptides 29 (2008) 1740-1748
18. Lukas G., Brindal S.D., and Reengard P. The route of absorption of intraperitoneally administered compounds. J Pharmacol Exp Ther 178 3 (1971) 562-566
19. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin-Phenol reagents. J Biol Chem 193 (1951) 265-275
20. Allain C.C., Poon L.S., Chan C.G.S., Richanond W., and Fu P.C. Enzymatic determination of total serum cholesterol. Clin Chem 20 (1974) 470-475
21. Taussky H.H., and Shorr E. A micro colorimetric method for the determination of inorganic phosphorus. J Biol Chem 202 (1953) 675-685
22. Jacobs N.J., and VanDemark P.J. The purification and properties of α-glycerophosphate-oxidizing enzyme of Streptococcus faecalis 10C1. Arch Biochem Biophys 88 (1960) 250-255
23. Williams P., Robinson D., and Bailey A. High density lipoprotein and coronary risk factor in normal man. Lancet 313 (1979) 72-75
24. Friedwald W.T., Levy R.I., and Fredrickson D.S. Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
25. Thefeld W., Hoffmeister H., Busch E.W., Koller P.U., and Vollmar J. Reference values for the determination of GOT, GPT and alkaline phosphatase in serum with optimum standard method. Dtsch Med Wochenschr 99 (1974) 343-344
26. Schlebusch H., Rich W., Lang H., and Knedel M. Standards in the activities of clinically important enzymes. Dtsch Med Wochenschr 99 (1974) 765-766
27. Weisshaar D., Gossrau E., and Faderl B. Normal ranges of alpha-HBDH, LDH, AP and LAP as measured with substrate optimated test charges. Med Welt 26 (1975) 387-392
28. Chartel N., Alvear-Perez R., Leprince J., Iturrioz X., Goazigo A.R., Audinot V., Chomarat P., Coge F., Nosjean O., Rodriguez M., Galizzi J.P., Boutin J.A., Vaudry H., and Llorens-Cortes C. Comments on obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 315 (2007) 766c